ARCHIVES

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

This article is from The Cancer Letter archive.

Vol. 23 No. 13 | April 4, 1997

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000

November 10, 1989

Referral Pattern Change Needed For Quality Care, AACR/ASCO Told

May 16, 1975

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005